InflaRx N.V.(IFRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IFRX InflaRx N.V.

休市中 05-03 16:00:00 EDT

1.38

+0.00

0.00%

盘后1.35

-0.03-2.17%

18:56 EDT

最高1.45	最低1.28	成交量17.94万
今开1.38	昨收1.38	日振幅12.26%
总市值8,126万	流通市值6,737万	总股本5,888万
成交额24.46万	换手率0.37%	流通股本4,882万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IFRX","market":"US","secType":"STK","nameCN":"InflaRx N.V.","latestPrice":1.38,"timestamp":1714766400000,"preClose":1.38,"halted":0,"volume":179383,"hourTrading":{"tag":"盘后","latestPrice":1.35,"preClose":1.38,"latestTime":"18:56 EDT","volume":155,"amount":211.65,"timestamp":1714777005033},"delay":0,"floatShares":48820951,"shares":58883272,"eps":-0.858426,"marketStatus":"休市中","marketStatusCode":7,"change":0,"latestTime":"05-03 16:00:00 EDT","open":1.38,"high":1.4492,"low":1.28,"amount":244623.57461689998,"amplitude":0.122609,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.858426,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"listingDate":1510117200000,"adjPreClose":1.38,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.4,"preClose":1.38,"latestTime":"08:38 EDT","volume":188,"amount":263.2,"timestamp":1714739896056},"postHourTrading":{"tag":"盘后","latestPrice":1.35,"preClose":1.38,"latestTime":"18:56 EDT","volume":155,"amount":211.65,"timestamp":1714777005033},"volumeRatio":1.2498623907137614},"requestUrl":"/m/hq/s/IFRX","defaultTab":"news","newsList":[{"id":"2432817959","title":"Inflarx N.V.盘中异动 大幅下挫6.38%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432817959","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432817959?lang=zh_cn&edition=full","pubTime":"2024-05-03 00:07","pubTimestamp":1714666027,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日00时07分，Inflarx N.V.股票出现波动，股价急速下跌6.38%。截至发稿，该股报1.32美元/股，成交量7.3643万股，换手率0.13%，振幅6.62%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.73%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050300070787e855ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050300070787e855ca&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431862926","title":"Inflarx N.V.盘中异动 早盘股价大涨6.02%报1.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431862926","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431862926?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:27","pubTimestamp":1714400838,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时27分，Inflarx N.V.股票出现异动，股价急速拉升6.02%。截至发稿，该股报1.41美元/股，成交量2.9752万股，换手率0.05%，振幅5.26%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.78%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292227187a573074&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292227187a573074&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430821727","title":"Inflarx N.V.盘中异动 急速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430821727","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430821727?lang=zh_cn&edition=full","pubTime":"2024-04-27 02:09","pubTimestamp":1714154995,"startTime":"0","endTime":"0","summary":"北京时间2024年04月27日02时09分，Inflarx N.V.股票出现波动，股价大幅下挫5.04%。截至发稿，该股报1.32美元/股，成交量5.1872万股，换手率0.09%，振幅7.12%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.47%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270209557a56548f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270209557a56548f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430284920","title":"Inflarx N.V.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430284920","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430284920?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:24","pubTimestamp":1714055094,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日22时24分，Inflarx N.V.股票出现异动，股价急速下挫5.15%。截至发稿，该股报1.29美元/股，成交量1.9577万股，换手率0.03%，振幅2.21%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为1.66%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522245487e83c14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522245487e83c14&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429113166","title":"Inflarx N.V.盘中异动 早盘快速上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429113166","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429113166?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:55","pubTimestamp":1713880508,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时55分，Inflarx N.V.股票出现波动，股价急速上涨5.11%。截至发稿，该股报1.44美元/股，成交量6581股，换手率0.01%，振幅1.09%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为1.22%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232155097922b10f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232155097922b10f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428507836","title":"Inflarx N.V.盘中异动 快速拉升5.95%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428507836","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428507836?lang=zh_cn&edition=full","pubTime":"2024-04-19 22:23","pubTimestamp":1713536587,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日22时23分，Inflarx N.V.股票出现异动，股价大幅拉升5.95%。截至发稿，该股报1.34美元/股，成交量4.0276万股，换手率0.07%，振幅3.97%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.56%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041922230887e8225d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041922230887e8225d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428959787","title":"Inflarx N.V.盘中异动 早盘快速拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428959787","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428959787?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:45","pubTimestamp":1713447943,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时45分，Inflarx N.V.股票出现波动，股价快速拉升5.14%。截至发稿，该股报1.33美元/股，成交量2.9179万股，换手率0.05%，振幅6.32%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.73%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182145437a53cab3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182145437a53cab3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428342885","title":"Inflarx N.V.盘中异动 快速下挫5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428342885","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428342885?lang=zh_cn&edition=full","pubTime":"2024-04-17 22:47","pubTimestamp":1713365221,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日22时47分，Inflarx N.V.股票出现异动，股价大幅跳水5.19%。截至发稿，该股报1.24美元/股，成交量11.984万股，换手率0.20%，振幅5.92%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.71%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041722470187e8166b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041722470187e8166b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427131874","title":"Inflarx N.V.盘中异动 临近午盘股价大跌5.03%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427131874","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427131874?lang=zh_cn&edition=full","pubTime":"2024-04-16 23:47","pubTimestamp":1713282436,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日23时47分，Inflarx N.V.股票出现波动，股价快速跳水5.03%。截至发稿，该股报1.32美元/股，成交量5.8928万股，换手率0.10%，振幅5.04%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.32%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416234716861e65b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416234716861e65b0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427517889","title":"Inflarx N.V.盘中异动 大幅下跌5.33%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427517889","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427517889?lang=zh_cn&edition=full","pubTime":"2024-04-16 01:04","pubTimestamp":1713200692,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日01时04分，Inflarx N.V.股票出现波动，股价急速下跌5.33%。截至发稿，该股报1.42美元/股，成交量7.0521万股，换手率0.12%，振幅4.67%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.13%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160104527a52e07b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160104527a52e07b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427752219","title":"Inflarx N.V.盘中异动 急速跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427752219","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427752219?lang=zh_cn&edition=full","pubTime":"2024-04-13 03:33","pubTimestamp":1712950409,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日03时33分，Inflarx N.V.股票出现波动，股价大幅下挫5.19%。截至发稿，该股报1.46美元/股，成交量15.3959万股，换手率0.26%，振幅5.84%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为1.66%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130333307a527bca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130333307a527bca&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426686572","title":"Inflarx N.V.盘中异动 早盘大幅拉升8.55%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426686572","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426686572?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:35","pubTimestamp":1712842502,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日21时35分，Inflarx N.V.股票出现波动，股价大幅上涨8.55%。截至发稿，该股报1.65美元/股，成交量6363股，换手率0.01%，振幅3.29%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.00%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112135028b1092da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112135028b1092da&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426492264","title":"Inflarx N.V.盘中异动 股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426492264","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426492264?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:49","pubTimestamp":1712756997,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时49分，Inflarx N.V.股票出现波动，股价快速跳水5.56%。截至发稿，该股报1.53美元/股，成交量1.4635万股，换手率0.02%，振幅3.08%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为1.35%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102149577a51e8b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102149577a51e8b5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426426231","title":"Inflarx N.V.盘中异动 下午盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426426231","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426426231?lang=zh_cn&edition=full","pubTime":"2024-04-10 02:44","pubTimestamp":1712688274,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日02时44分，Inflarx N.V.股票出现异动，股价快速拉升5.26%。截至发稿，该股报1.60美元/股，成交量24.5万股，换手率0.42%，振幅5.92%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.45%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404100244347a51aa90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404100244347a51aa90&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425990227","title":"Inflarx N.V.盘中异动 早盘快速上涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425990227","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425990227?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:31","pubTimestamp":1712583102,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时31分，Inflarx N.V.股票出现波动，股价快速上涨5.81%。截至发稿，该股报1.64美元/股，成交量1157股，换手率0.00%，振幅1.29%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.10%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408213142791f2bef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408213142791f2bef&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425564386","title":"Inflarx N.V.盘中异动 早盘股价大涨5.13%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425564386","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425564386?lang=zh_cn&edition=full","pubTime":"2024-04-05 22:33","pubTimestamp":1712327615,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日22时33分，Inflarx N.V.股票出现异动，股价快速拉升5.13%。截至发稿，该股报1.64美元/股，成交量5.681万股，换手率0.10%，振幅7.05%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.46%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405223336791edae9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405223336791edae9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424827185","title":"Inflarx N.V.盘中异动 股价大涨6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424827185","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424827185?lang=zh_cn&edition=full","pubTime":"2024-04-04 01:16","pubTimestamp":1712164573,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日01时16分，Inflarx N.V.股票出现异动，股价快速拉升6.49%。截至发稿，该股报1.64美元/股，成交量12.9085万股，换手率0.22%，振幅6.17%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.18%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404011614861e35c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404011614861e35c2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422487155","title":"Inflarx N.V.盘中异动 大幅上涨6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422487155","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422487155?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:44","pubTimestamp":1711374266,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时44分，Inflarx N.V.股票出现波动，股价急速上涨6.04%。截至发稿，该股报1.58美元/股，成交量3564股，换手率0.01%，振幅0.00%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.06%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252144267a4ee888&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252144267a4ee888&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421456460","title":"Inflarx N.V.盘中异动 早盘股价大跌17.10%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421456460","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421456460?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:31","pubTimestamp":1711027881,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时31分，Inflarx N.V.股票出现波动，股价快速下挫17.10%。截至发稿，该股报1.40美元/股，成交量10.9811万股，换手率0.19%，振幅2.96%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.64%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212131218b511d1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212131218b511d1f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420408602","title":"Inflarx N.V.盘中异动 大幅下挫5.06%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420408602","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420408602?lang=zh_cn&edition=full","pubTime":"2024-03-18 22:34","pubTimestamp":1710772470,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日22时34分，Inflarx N.V.股票出现异动，股价快速跳水5.06%。截至发稿，该股报1.50美元/股，成交量3.1382万股，换手率0.05%，振幅4.37%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.46%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031822343187e79c8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031822343187e79c8a&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inflarx.com","stockEarnings":[{"period":"1week","weight":0.0376},{"period":"1month","weight":-0.1097},{"period":"3month","weight":-0.1481},{"period":"6month","weight":0},{"period":"1year","weight":-0.6927},{"period":"ytd","weight":-0.1534}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"InflaRx N.V.于2017年6月根据荷兰法律成立，根据公司重组的条款，该公司是一家InflaRx GmbH的控股的公司。该公司是一家临床阶段的生物制药公司，专注于应用其独有的反C5a技术来发现和开发一种名为C5a的补充激活因子的一级、有效和特异性抑制剂。C5a是一种强大的炎症介质，涉及多种自身免疫和其他炎症疾病的进展。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.090583},{"month":2,"riseRate":0.571429,"avgChangeRate":0.006427},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.068353},{"month":4,"riseRate":0.571429,"avgChangeRate":0.389384},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.055183},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.26601},{"month":7,"riseRate":0.333333,"avgChangeRate":0.114861},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.053477},{"month":9,"riseRate":0.5,"avgChangeRate":-0.032601},{"month":10,"riseRate":0.333333,"avgChangeRate":0.016141},{"month":11,"riseRate":0.5,"avgChangeRate":0.042008},{"month":12,"riseRate":0.714286,"avgChangeRate":0.137243}],"exchange":"NASDAQ","name":"InflaRx N.V.","nameEN":"InflaRx N.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"InflaRx N.V.(IFRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供InflaRx N.V.(IFRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"InflaRx N.V.,IFRX,InflaRx N.V.股票,InflaRx N.V.股票老虎,InflaRx N.V.股票老虎国际,InflaRx N.V.行情,InflaRx N.V.股票行情,InflaRx N.V.股价,InflaRx N.V.股市,InflaRx N.V.股票价格,InflaRx N.V.股票交易,InflaRx N.V.股票购买,InflaRx N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"InflaRx N.V.(IFRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供InflaRx N.V.(IFRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}